Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024 J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;

Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study C. von Muhlenbrock; G. Landskron; A.M. Madrid;

Immune dysregulation and pathophysiology of alcohol consumption and alcoholic liver disease M. Martinez-Castillo; I. Altamirano-Mendoza; S. Sánchez-Valle; L. García-Islas; M. Sánchez-Barragán; M. Hernández-Santillán; A. Hernández-Barragán; J.L. Pérez-Hernández; F. Higuera-de la Tijera; G. Gutierrez-Reyes;